Acadia Pharmaceuticals | ACAD - Interest Income


Acadia Pharmaceuticals reported $7.99M in Interest Income for its fiscal quarter ending in June of 2026.





Interest Income Change Date
Acadia Pharmaceuticals USD 7.99M 65K Jun/2026
ALKERMES USD 8.54M 3.59M Mar/2026
Alnylam Pharmaceuticals USD 28.14M 1.54M Jun/2026
Biogen USD 25.3M 12.6M Jun/2026
BioMarin Pharmaceutical USD 10.48M 12.08M Jun/2026
Cara Therapeutics USD 347K 74K Mar/2025
Corcept Therapeutics USD 4.63M 255K Jun/2026
Cytokinetics USD 13.94M 2.92M Jun/2026
Eisai JPY 3.11B 783M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Incyte USD 38.12M 4.43M Jun/2026
J&J USD 0.09 2.18 Sep/2026
Moderna USD 67M 5M Jun/2026
Pfizer USD 0.56 0.6 Sep/2026
Prothena USD 2.55M 137K Jun/2026
Sarepta Therapeutics USD 7.16M 160K Jun/2026
Ultragenyx Pharmaceutical USD 5M 1000K Jun/2026
Vertex Pharmaceuticals USD 120.6M 5.8M Jun/2026